Dow Up 0.36% Nasdaq Up 0.12%

Dendreon Corp. (DNDN)

-NasdaqGS
1.35 Aug 21, 4:00PM EDT
Prev Close:1.35
Open:N/A
Bid:1.32 x 1000
Ask:1.35 x 1500
1y Target Est:1.83
Beta:3.77
Earnings Date:Aug 25 - Aug 29 (Est.)
Day's Range:N/A - N/A
52wk Range:1.24 - 3.52
Volume:0
Avg Vol (3m):2,277,220
Market Cap:209.05M
P/E (ttm):N/A
EPS (ttm):-1.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DNDN 0.00%209.05M
NWBO366.54M
PGNX356.12M
SNY141.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.76
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:3.7
PEG Ratio (5 yr expected):-0.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dendreon Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback